Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
225.33
-5.47 (-2.37%)
At close: May 29, 2026, 4:00 PM EDT
225.46
+0.13 (0.06%)
After-hours: May 29, 2026, 7:59 PM EDT

Johnson & Johnson Revenue

Johnson & Johnson had revenue of $24.06B in the quarter ending March 31, 2026, with 9.91% growth. This brings the company's revenue in the last twelve months to $96.36B, up 7.87% year-over-year. In the year 2025, Johnson & Johnson had annual revenue of $94.19B with 6.05% growth.

Revenue (ttm)
$96.36B
Revenue Growth
+7.87%
P/S Ratio
5.63
Revenue / Employee
$697,265
Employees
138,200
Market Cap
542.42B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202594.19B5.37B6.05%
Dec 31, 202488.82B3.66B4.30%
Dec 31, 202385.16B5.17B6.46%
Jan 1, 202379.99B1.25B1.59%
Jan 2, 202278.74B-3.84B-4.65%
Jan 3, 202182.58B525.00M0.64%
Dec 31, 201982.06B478.00M0.59%
Dec 31, 201881.58B5.13B6.71%
Dec 31, 201776.45B4.56B6.34%
Jan 1, 201771.89B1.82B2.59%
Jan 3, 201670.07B-4.26B-5.73%
Dec 31, 201474.33B3.02B4.23%
Dec 31, 201371.31B4.09B6.08%
Dec 30, 201267.22B2.19B3.37%
Jan 1, 201265.03B3.44B5.59%
Jan 2, 201161.59B-310.00M-0.50%
Jan 3, 201061.90B-1.85B-2.90%
Dec 28, 200863.75B2.65B4.34%
Dec 30, 200761.10B7.77B14.57%
Dec 31, 200653.32B2.81B5.56%
Jan 1, 200650.51B3.17B6.69%
Jan 2, 200547.35B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Eli Lilly and Company72.25B
Merck & Co.65.77B
Pfizer63.32B
AbbVie62.82B
AstraZeneca60.44B
Novartis AG56.58B
Sanofi54.60B
Novo Nordisk50.57B
Revenue Rankings